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The role of protein phosphorylation in the life cycle of malaria parasites is slowly emerging. Here 
we combine global phospho-proteomic analysis with kinome-wide reverse genetics to assess 
the importance of protein phosphorylation in Plasmodium falciparum asexual proliferation. 
We identify 1177 phosphorylation sites on 650 parasite proteins that are involved in a wide 
range of general cellular activities such as DnA synthesis, transcription and metabolism as 
well as key parasite processes such as invasion and cyto-adherence. several parasite protein 
kinases are themselves phosphorylated on putative regulatory residues, including tyrosines in 
the activation loop of PfGsK3 and PfCLK3; we show that phosphorylation of PfCLK3 Y526 is 
essential for full kinase activity. A kinome-wide reverse genetics strategy identified 36 parasite 
kinases as likely essential for erythrocytic schizogony. These studies not only reveal processes 
that are regulated by protein phosphorylation, but also define potential anti-malarial drug 
targets within the parasite kinome. 
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Malaria still kills over 1 million people a year and is a source of morbidity that represents a serious barrier to the social and economic progress of many second and third world 
countries1. Surprisingly, despite the fact that protein phosphoryla-
tion is a universal regulatory mechanism demonstrated as a drug-
gable target in many human diseases, the potential of targeting the 
largely divergent protein kinases and phospho-signalling cascades 
of malaria parasites has been unexploited2,3. One of the factors con-
tributing to this neglect is the serious paucity of information regard-
ing the role played by phosphorylation in the biology of the most 
virulent human malaria parasite, Plasmodium falciparum.
Two independent genomic analyses identified 86 (ref. 4) or 99 
(ref. 5) genes encoding putative protein kinases in P. falciparum 
representing 1.1–1.6% of the coding genes, of which 65 are clearly 
related to the eukaryotic protein kinase (ePK) family. Many of the 
65 P. falciparum ePKs can be assigned to the familiar AGC, CMGC, 
CK1, CaMK and tyrosine-kinase like groups observed in the human 
kinome6. In this respect the malarial and human kinomes are simi-
lar in that they are large and diverse gene families, which, certainly 
in the case of the human kinome, underlies multiple modes of regu-
lation and diverse cellular substrates. Despite this overall similarity, 
however, sequence homology between malarial and mammalian 
protein kinases is limited in many instances, and as a consequence 
many Plasmodium protein kinases have no orthologues in the human 
host. These include the calcium-dependent kinases (CDPKs) that 
closely resemble plant kinases where the kinase domain is fused to a 
calmodulin-like domain7, and the FIKKs, which comprises the larg-
est kinase family in P. falciparum with 21 members, and is restricted 
to Apicomplexan parasites4,8. Furthermore, there are some notably 
absent protein kinase classes in P. falciparum. In particular, there 
seems to be no members of the tyrosine kinase group, and no clearly 
recognizable MAPKK homologue, a family of the STE group.
The significant phylogenetic diversity between the human and 
malarial kinomes could possibly provide the basis for selective tar-
geting of the malarial kinome2. Although this is an attractive notion, 
there is very little information regarding the role of protein phospho-
rylation in Plasmodium biology, and hence predicting the potential 
efficacy and cellular effects of drugs targeting malarial kinases and 
phosphorylation pathways is difficult.
It is in this light that we have combined kinome-wide gene 
knockout and reverse genetics approaches together with global 
phospho-proteomics to probe the importance of protein phospho-
rylation in the asexual intra-erythrocytic stages of P. falciparum. 
Our study shows that ~half of the 65 ePKs that make up the P. 
falciparum kinome are likely to be essential for the maintenance of 
parasite viability. This surprising lack of redundancy points not only 
to the pivotal role of a number of individual protein kinases but also 
to a potentially abundant source of anti-malarial protein kinase tar-
gets. That these protein kinases regulate a diverse range of biological 
activities is evident by the nature of the phospho-proteome, which 
we show here includes proteins involved in many key processes such 
as invasion into red blood cells, metabolism, transcription and DNA 
replication. The complexity of protein phosphorylation in malaria 
parasites was further underlined by our observation that despite 
the absence of a classical tyrosine kinase family in P. falciparum, 
tyrosine phosphorylation does indeed occur in the parasite. This is 
exemplified by the protein kinase PfCLK3 (PF11_0156), which is 
phosphorylated on tyrosine within the activation loop in a manner 
consistent with this kinase being a member of the dual-specificity 
tyrosine phosphorylated-regulated kinase (DYRK) family.
Results
Kinome-wide reverse genetics in P. falciparum. To identify protein 
kinases that are essential for asexual proliferation, and hence 
represent potential targets for curative intervention, we attempted 
to inactivate each of the entire complement of 65 ePK genes that 
constitute the P. falciparum kinome4 (this study does not include 
FIKKs, a novel divergent, Apicomplexa-specific kinase-like family 
we identified in our initial kinome analysis). This was achieved 
following a homologous recombination, single crossover gene 
disruption strategy (Supplementary Figs S1–S3). Integration of the 
KO vectors into the genome of transfected parasites (clone 3D7) was 
monitored by PCR and/or Southern blot analysis (Supplementary 
Fig. S4).
Integration of the KO vector was not observed after a prolonged 
(at least 90 days) culture for 27 ePK genes, indicating that the 
enzymes encoded by these genes likely have crucial roles in para-
site asexual proliferation (Table 1). For the majority (22) of these 
27 loci, we separately transfected 3D7 parasites with tagging vec-
tors designed to place a C-terminal tag (haemagglutinin, Myc or 
green fluorescent protein) in-frame with the ePK coding sequence 
(Supplementary Fig. S1). In all cases except PfPK6 (PF13_0206) and 
PfCLK3 (PF11_0156), targeting of the locus with the epitope tag was 
successful (Table 1, Supplementary Fig. S1; Supplementary Table 
S1); the lack of success in tagging PfPK6 and PfCLK3 may reflect 
a deleterious effect of the tag on enzyme function. For 3 of the 27 
genes that could not be disrupted by the KO vector alone (PfCK2 
(PF11_0096), PfPK9 (PF13_0085) and Pfmap-2 (PF11_0147)), we 
were able to achieve gene disruption if the function was comple-
mented through co-transfection of the ePK of interest under the 
control of the P. falciparum Hsp86 promoter (Table 1, Supplemen-
tary Fig. S2). This complementation approach can now be applied 
for detailed functional investigations of these enzymes, for example, 
by examining the effect of specific mutations in the complementing 
gene, notably gatekeeper residue mutations that confer hypersensi-
tivity to bulky inhibitors (see below).
Taken together, the tagging and complementation approaches 
strongly suggest that for 22 ePKs the absence of integration of the 
KO vector is not caused by locus refractoriness to recombination 
but rather is likely due to the fact that these ePKs have a crucial role 
in the erythrocytic asexual cycle, the process that is responsible for 
malaria pathogenesis. Among these 22 ePKs are 8 enzymes that we 
previously reported as playing a crucial role in asexual prolifera-
tion: Pfmap-2 (PF11_0147)9, Pfnek-1 (PFL1370w)10, PfCK2 (PF11_
0096)11, PfTKL3 (PF13_0258)12, Pfcrk-3 (PFD0740w)13, PfCLK1 
(PF14_0431)14, PfCLK2 (PF14_0408)14 and PfARK1 (PF13_0258)15. 
Others have provided reverse genetics evidence for essentiality of 
three additional ePKs, PfCDPK1 (PFB0815w)16, PfPKG (PF14_
0346)17 and PfPCDPK5 (PF13_0211)18. Hence, the present study 
brings to 25 the number of ePKs that are highly likely to have 
a crucial role in the erythrocytic asexual cycle of P. falciparum  
(highlighted in bold in Table 1).
In contrast, we detected integration of the KO vector into the 
gene loci of 32 ePKs. In six cases (indicated by flanking asterisks in 
Table 1), the signals were very weak even after prolonged culture; 
we propose that the weak PCR signal diagnostic for integration of 
the KO vector indicates that integration occurs transiently during 
schizogony but that parasites with a disrupted locus do not persist. 
We consider these genes are likely to be essential; genotyping of 
cloned populations will be required to validate this interpretation 
for this subset of ePK genes. In the case of one of these kinases, 
the cyclic AMP (cAMP)-dependent kinase PfPKA, an essential role 
is further supported by the observation that transgenic parasites 
expressing mutant cAMP-dependent phosphorylation sites in the 
apical membrane antigen 1 protein are significantly impaired in the 
invasion process19.
For 25 ePKs genes, a strong signal was obtained for integration of 
the KO vector in transfected populations, suggesting that the prod-
ucts of these genes are not essential for completion of the asexual 
intra-erythrocytic cycle, or that other protein kinases can compen-
sate for the inactivated gene (Table 2). This was firmly established 
for 12 of these, for which parasite clones with a disrupted locus were 
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obtained by limited dilution. In addition, PfCDPK4 (PF07_0072) 
was previously identified by Kato et al.16 as being dispensable for 
asexual growth.
In summary, our initial assessment of essential function indicates 
that of the 65 ePks in the P. falciparum kinome, 36 ePKs are likely 
to have a crucial role in the P. falciparum erythrocytic asexual cycle 
(Table 1). In contrast, 12 are definitely dispensable, as evidenced by 
viable parasite clones in which the relevant genes are inactivated 
(indicated in bold in Table 2) and a further 14 are likely dispensable 
(indicated by flanking asterisks in Table 2).
Global phospho-proteome of P. falciparum. In order to provide a 
comprehensive picture of the malarial phospho-proteome we under-
took a mass spectrometry-based global phospho-proteomic study 
of the late schizont stage of P. falciparum. Following lysis of puri-
fied schizonts in 1% NP-40 the entire infected red blood cell extract 
was processed as summarized in Figure 1a. This process identified 
676 phosphoproteins, of which 26 were human proteins and 650 
were from the parasite (Supplementary Data 1 and 2). In total we 
identified 1223 individual phosphorylation sites, the vast major-
ity of which (1177) occurred on proteins encoded by the parasite 
(Fig. 1b). Supplementary Data 1 and 2 provide a full list of human 
and parasite phospho-proteins and phospho-sites, respectively. 
The phospho-peptides presented in these spread sheets have been 
observed in at least two of the six biological replicates analysed and 
were derived from a total data set of 3289 unique phospho-peptides 
which were filtered using stringent criteria that included compu-
tational analysis and manual inspection of each MS/MS spectrum 
(see Supplementary  Methods). A SCAFFOLD file containing all the 
MS/MS data from this study can be downloaded as described in the 
methods section.
In addition to the identification of phospho-proteins involved in 
general cellular activities such as metabolism, DNA replication and 
gene transcription (Fig. 1b), many of the phospho-proteins were 
associated with parasite-specific processes such as cyto-adhesion 
(for example, knob-associated histidine-rich protein (PFB0100c)), 
a process that is central to malaria pathogenesis (Supplementary 
Data 2). Parasite invasion into red blood cells is a complex proc-
ess involving merozoite binding, reorientation, shedding of mero-
zoite coat proteins and invasion per se20. We show here that proteins 
involved in this process are phosphorylated including the micro-
neme protein apical membrane antigen 1 (PF11_0344) (Fig. 2a, 
Table 3), a protein whose phosphorylation was previously shown to 
be important for invasion19, and the merozoite cell surface proteins 
MSP1 and MSP7 (Supplementary Data 2), together with proteins 
associated with the rhoptries, specialized organelles at the apical 
Table 1 | PKs considered as likely essential for the erythrocyte asexual cycle.
PlasmoDB identifier Name Protein kinase group/family Remarks Reference
PF11_0377 PfCK1 Casein Kinase 1 This study
PF13_0258 PfTKL3 Tyrosine kinase-like  12
PFB0520w PfTKL1 Tyrosine kinase-like This study
PFF1370w PfPK4 eIF2α kinase This study
PFL1370w Pfnek-1 NimA  10
PFC0755c Pfcrk-4 CMGC/CDK This study
*PF13_0206* PfPK6 CmGC/CDK This study
PFD0740w Pfcrk-3 CMGC/CDK  13
MAL13P1.279 PfPK5 CMGC/CDK This study
PF10_0141 Pfmrk CMGC/CDK This study
*PFD0865c* Pfcrk-1 CmGC/CDK This study
PF11_0147 Pfmap-2 CMGC/MAPK Complemented  9
PF11_0096 PfCK2 CMGC/CK2 Complemented  11
*mAL13P1.84* — CmGC/GsK3 This study
PFC0525c PfGSK3 CMGC/GSK3 This study
*PF11_0156* PfCLK3 CmGC/CDK-like This study
PF14_0431 PfCLK1/Pflammer CMGC/CDK-like  14
PFC0105w PfCLK4 CMGC/CDK-like This study
PF14_0408 PfCLK2 CMGC/CDK-like  14
*PFL1885c* PfPK2 CamK This study
PFB0815w PfCDPK1 CDPK  16
PF13_0211 PfCDPK5 CDPK  18
*PFF0520w* PfCDPK2 CDPK This study
*PFC0420w* PfCDPK3 CDPK This study
PFF0260w PfARK1 Aurora  15
PFC0385c PfARK2 Aurora This study
MAL13P1.278 PfARK3 Aurora This study
*PF11_0464* — AGC-related This study
*PF11_0227* — AGC-related This study
PF14_0346 PfPKG AGC  17
PFL2250c PfPKB AGC This study
*PFI1685w* PfPKA AGC This study
*mAL7P1.91* PfEsT orphan This study
PF11_0488 — Orphan This study
PF14_0516 PfKIN Orphan This study
PF13_0085 PfPK9 Orphan Complemented This study
Bold characters indicate those genes for which integration of the Ko vector was not achieved and accessibility of the locus to recombination was verified by C-terminal tagging. Those for which locus 
disruption was achieved only in the presence of a complementing episome expressing the protein are indicated by the label ‘complemented’. The 25 genes include three (PfCDPK1, PfCDPK5 and 
PfPKG) that have been demonstrated as essential by other authors.
Genes highlighted by flanking asterisks (11 genes) are also considered as likely essential, although the criteria used to define essentiality were not fully met. For 5 of these 11 genes, no integration of the 
Ko vector was observed, but locus accessibility to recombination was not verified (it was attempted but was unsuccessful for PfPK6 and PfCLK3, and not done for the others).
ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1558
nATuRE CommunICATIons | 2:565 | DoI: 10.1038/ncomms1558 | www.nature.com/naturecommunications
© 2011 Macmillan Publishers Limited. All rights reserved.
pole of merozoites that release proteins during the invasion proc-
ess21 (Fig. 2a, Table 3). The phosphorylation status of one of these 
rhoptry proteins, CLAG 3.1, that forms part of the RhopH complex 
proposed to have a role in erythrocyte binding21, formation/function 
of the parasitophorous vacuole21,22, cyto-adherence23 and invasion21, 
was confirmed using an anti-phospho antibody raised against pS1382 
(Fig. 2b–d). This antibody identified a punctuate localization of 
phospho-CLAG 3.1 consistent with rhoptry localization within 
merozoites of a mature schizont (Fig. 2e). A recent report implicat-
ing CLAG3.1 in the machinery that imports nutrient in the infected 
red blood cell24 suggests that phosphorylation may also regulate this 
process, which is fundamental in parasite survival.
Activation loop threonine phosphorylation of parasite protein 
kinases. The global phospho-proteomic study revealed that at 
least 23 protein kinases are phospho-proteins (Table 4) and that a 
number of these phosphorylation events occurred within the acti-
vation loop, a process that is often necessary for the full activation 
of protein kinases25. These included activation loop phosphoryla-
tion of T189 on PfPKA (PFI1685w) and T695 on PfPKG (PF14_0346) 
in a manner that resembles activation loop phosphorylation in the 
mammalian orthologues, which is necessary for full kinase activ-
ity. These phosphorylation sites were confirmed in a phospho-pro-
teomic study conducted by Drs Edwin Lasonder and Pietro Alano 
(personal communication), and by western blot experiments using 
anti-phospho T189 antibodies to PfPKA and anti-phospho T695 anti-
bodies to PfPKG (Supplementary Fig. S5).
The essential P. falciparum cyclin-dependent protein kinases 
Pfcrk-1 (PFD0865c) and Pfcrk-3 (PFD0740w) (Table 1) are also 
phosphorylated on threonine residues within the activation loop. 
This may well represent dynamic/regulatory phosphorylation analo-
gous to that observed for the mammalian and fungal cyclin-depend-
ent kinases (CDKs) that require both cyclin binding and the activa-
tion loop threonine phosphorylation for full activity26. In the case of 
the mammalian CDKs, this phosphorylation is mediated through a 
CDK-activating kinase. A good candidate for such a kinase acting 
upstream of Pfcrk-1 and Pfcrk-3 in P. falciparum would be Pfmrk 
(PF10_0141), a CDK that displays closest homology to CDK-7, the 
CDK-activating kinase mammalian homologue.
Activation loop tyrosine phosphorylation of parasite protein 
kinases. Despite the lack of a recognized tyrosine kinase family27 in 
the P. falciparum kinome, phospho-amino acid analysis of metaboli-
cally labelled schizonts revealed trace amounts of phospho-tyrosine 
( < 1% of total protein phosphorylation) (Fig. 3a,b). Furthermore, using 
anti-phosphotyrosine antibodies we demonstrated that infected 
red blood cells (RBCs) undergo a substantial increase in tyrosine 
phosphorylation over non-infected controls, and that the majority 
of this tyrosine phosphorylation was detectable within the parasite 
fraction (Fig. 3c). It seems therefore that tyrosine phosphorylation 
may occur within the parasitophorous vacuole (including within the 
parasite itself) rather than exclusively in the host erythrocyte.
The clearest example of tyrosine-phosphorylated parasite pro-
teins emerging from the global phosphorylation analysis was tyro-
sine phosphorylation of parasite protein kinases within the activa-
tion loop. Tyrosine 229 within the activation loop of P. falciparum 
glycogen synthase kinase 3 (PfGSK3) (PFC0525c), an enzyme that 
is likely essential for asexual proliferation (Table 1), was observed to 
be phosphorylated (Fig. 3d–g). This site is analogous to Y279 and Y216 
on mammalian GSK3α/β, the activation loop auto-phosphorylation 
sites necessary for enzymatic activity28. We exploited the fact that 
antibodies to human GSK3α/β (pY276/216) cross-react with PfGSK3 
(Fig. 3f) to confirm that PfGSK3 was indeed phosphorylated on 
Y229 at the schizont stage (Fig. 3g). Furthermore, we showed that 
PfGSK3 expressed as a recombinant protein in bacteria was also 
phosphorylated on Y229 (Fig. 3f), suggesting that this phosphoryla-
Table 2 | PKs considered as likely dispensable for the erythrocyte asexual cycle.
PlasmoDB identifier Name Protein kinase group/family Remarks Reference
*PF11_0220* PfTKL2 Tyrosine kinase-like This study
PFF1145c PfTKL4 Tyrosine kinase-like Cloned This study
PFA0380w PfeiK1 eIF2α kinase Cloned  33
PF14_0423 PfeiK2 eIF2α kinase Cloned  34
PFL0080c Pfnek-3 NimA Cloned This study
PFE1290w Pfnek-2 NimA Cloned  36
*mAL7P1.100* Pfnek-4 nimA This study
*mAL13P1.196* — CmGC/CDK This study
PFF0750w Pfcrk-5 CMGC/CDK Cloned This study
PF14_0294 Pfmap-1 CMGC/MAPK Cloned  9
*PF08_0044* PfPK1 CmGC/GsK3 This study
*PF11_0242* PfCDPK7 CDPK This study
*PF07_0072* PfCDPK4 CDPK  16
*PF11_0239* — CamK This study
PF14_0227 CamK Cloned This study
PFC0485w PfPKRP CamK Cloned This study
*PFB0665w* — CamK This study
*mAL7P1.18* — CamK This study
*PF11_0060* — CamK This study
*PFB0150c* PfPK8 orphan This study
*PFI1280c* — orphan This study
*PF14_0392* — orphan This study
MAL7P1.73 — Orphan Cloned This study
PF14_0476 — Orphan Cloned This study
PFB0605w PfPK7 Orphan Cloned  32
*PFL2280w* — orphan This study
Bold characters indicate those genes that are clearly dispensable for completion of the asexual erythrocytic cycle, as evidenced by the fact that parasite clones with a disrupted locus (and with a loss 
of the wild-type locus) could be obtained in the absence of complementation in the present study.
Genes highlighted by flanking asterisks (11 genes) are those for which a strong signal diagnostic for gene disruption was observed in transfected populations, and are therefore likely dispensable for 
completion of the asexual erythrocytic cycle. This category also includes one gene (PfCDPK4) that has been previously identified by Kato et al.16 as dispensable for asexual proliferation.
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tion event arises by auto-phosphorylation, as observed for mam-
malian GSK3α/β28.
Further tyrosine phosphorylation was detected within the activa-
tion loop of the P. falciparum protein kinase PfCLK3 (PF11_0156) 
(Fig. 4a,b), which is also likely to be an essential kinase (Table 1) and 
is related to the pre-mRNA processing kinase hPRP4 found in higher 
eukaryotes4. Phylogenetic analysis shows that these two kinases belong 
to a cluster that also includes the DYRKs sub-family4,29. The DYRKs are 
serine/threonine kinases of the CMGC kinase family that are character-
ized by the formation of an active transient intermediate during trans-
lation that is able to catalyse cis-auto-phosphorylate on tyrosine29,30. 
This process is proposed to be essential for full catalytic activity of the 
mature form of the enzyme, which then shows only serine/threonine 
kinase activity. Unlike most DYRKs that have a YXY motif in the 
activation loop where the second Y is the site of auto-phosphoryla-
tion29, PfCLK3 contains an TSY motif in the same position. The global 
phosphorylation study determined that tyrosine 526 within this 
motif in PfCLK3 was phosphorylated in vivo (Fig. 4a,b), an observa-
tion confirmed by using an anti-phosphopeptide antibody against 
pY526 (Fig. 4c,d) that was able to identify pY526 on PfCLK3 immuno-
precipitated from schizont stage-infected red blood cells (Fig. 4e).
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Figure 1 | Global phospho-proteomic analysis of the schizont stage of 
P. falciparum. (a) schematic illustration of the protocol of tryptic phospho-
peptide preparation and enrichment from a 1% nP-40 lysate of the 
schizont stage (36–40 h) of P. falciparum. This protocol was conducted 
on six biological replicates to generate the list of phosphorylation sites 
summarized in this figure and detailed in the supplementary Data 1 and 
2. (ACn; acetonitrile, ImAC; immobilised metal affinity chromatography, 
Tio2; titanium dioxide). (b) Histogram representing fractional distribution 
of functionally different groups of parasite phospho-proteins. uniprot 
accessions of the identified Plasmodium falciparum phospho-proteins 
were imported into Blast2Go and Blast searching was carried out against 
the nCBI non-redundant protein database. Gene ontology mapping and 
further annotation were performed using default Blast2Go parameters.
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Rabbit polyclonal antibodies were raised against this sequence.
The polyclonal antibody contained both phospho-specific and
non-phosphospecific antibodies. We have purified high-quality
phospho-specific antibodies for use in western blots and
immunocytochemistry.
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Figure 2 | Phosphorylation status of microneme and rhoptry proteins. 
(a) schematic summary of the rhoptry and microneme phospho-proteins. 
(b) Illustration of the sequence to which phospho-specific CLAG 3.1 
antibodies were raised. (c) Lysates from schizont stage-infected RBCs 
were fractionated on an RQ ion exchange column. A sample from each 
fraction was resolved by sDs-polyacrylamide gel electrophoresis and the 
gel probed with anti-phospho CLAG 3.1 antibody. shown are the results 
from fractions 9 to 13 from the RQ column elution. (d) To determine if the 
antibody recognized the phosphorylated form of CLAG 3.1, fraction 11 from 
the RQ column was treated with calf intestinal phosphatase to remove  
all phosphorylation. Control samples were not treated with phosphatase. 
The fraction was then probed with the anti-phospho CLAG 3.1 antibody. (e) 
The anti-phospho-CLAG 3.1 antibody was used to determine the localization 
of phospho-CLAG 3.1 by immunocytochemistry of paraformaldehyde-fixed 
schizont stage parasites. shown are two examples of schizont (segmenter) 
parasites stained with the phospho-CLAG 3.1 antibody. The samples were 
also stained with 4,6-diamidino-2-phenylindole (blue) to label the nuclei. 
The scale bar indicates 2 µm. The experiments shown are representative of 
at least three independent experiments.
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That this phosphorylation on PfCLK3 was likely to be due to 
auto-phosphorylation was evidenced by the fact that bacterially 
expressed PfCLK3 was phosphorylated on tyrosine 526 (Fig. 4c). 
Furthermore, we determined that bacterially expressed PfCLK3 was 
able to phosphorylate myelin basic protein in vitro (Fig. 4f). Using 
this assay we probed the importance of pY526 phosphorylation and 
determined that PfCLK3 activity was reduced by ~60% following 
mutation of the Y526-F (Fig. 4g). These findings are consistent with 
the notion that this protein kinase is a DYRK. Hence, our data point 
to constitutive auto-phosphorylation of PfCLK3 at tyrosine 526 
being important for enzymatic activity but that further regulation 
by either controlling expression levels, subcellular localization or via 
additional phosphorylation outside the activation loop may also be 
in operation to fine tune PfCLK3 kinase activity.
In addition to ePK activation loops, our phosphoproteome also 
detected tyrosine phosphorylation on a small number of non-kinase 
proteins that are located within the parasite, such as the DNA-rep-
licating factor PfMCM2 (PF14_0177). These tyrosine-phospho-
rylated proteins were, however, only observed in one biological 
replicate and as such are not included in Supplementary Data 2 
(although they are present in the SCAFFOLD file). The fact that 
we only saw these tyrosine phospho-peptides once might be due to 
the extremely low abundance of tyrosine-phosphorylated proteins 
as indicated from the phospho-amino acid analysis (Fig. 3b). The 
presence of these rare peptides does, however, suggest that some of 
the parasite’s serine/threonine protein kinase/s possess dual specifi-
city and are able to also phosphorylate tyrosine residues, as has been 
established in other ePKs, for example protein kinase CK231. We are 
currently investigating this possibility.
Discussion
The reverse genetics study we present here attempts to determine 
which of the parasite ePKs are required for completion of the asex-
ual cycle in erythrocytes. Interestingly, comparing Tables 1 and  2 
indicates that the various ePK groups and families are not distrib-
uted evenly between the essential and non-essential kinases. For 
example, almost all the CMGC group kinases and all aurora-related 
kinases seem to be essential for the asexual cycle, whereas 3 out 
of 4 NimA-related kinases are dispensable, illustrating the differ-
ent requirements for specific functions at distinct stages of the life 
cycle.
Formal demonstration of non-essentiality requires genotyping 
of clonal lines, which at present has been achieved for 12 of the 26 
ePKs genes in Table 2 (Supplementary Table S1 and Supplementary 
Fig. S3 for a specific example). Although it is highly likely that the 
remaining 14 kinases (those highlighted with asterisks in Table 2) 
are dispensable for asexual growth, definitive demonstration of this 
awaits the generation and genotyping of cloned populations.
Although most parasites with an inactivated ePK gene did not 
show any obvious growth defects, we observed two instances (PfPK7 
(PFB0605w)32 and Pfcrk-5 (PFF0750w)) where the ePK disruptants 
showed a slow parasitemia growth curve (typical growth curves are 
displayed in Supplementary Figs S6 and S7) in addition to geno-
typing data for these two genes); a detailed study of the PfPK7 KO 
phenotype has been published32. There may be additional kinases 
whose deletion causes a growth phenotype; comprehensive evalua-
tion in this respect has to await availability of clones for all instances 
where gene disruption has been achieved. Two of the dispensable 
ePKs, PfeIK1 and PfeIK2, are from the ‘eukaryotic initiation factor 
2α kinase’ family. PfeIK1 is expressed in asexual parasites, and was 
shown to be required for starvation-dependent phosphorylation of 
PfeIF2α during the erythrocytic cycle33 whereas PfeIK2 is expressed 
predominantly during sexual development and is required to pre-
vent premature translation of liver stage-specific genes in salivary 
gland sporozoites34. Interestingly, the third eIF2α kinase in the P. 
falciparum kinome, PfPK4, seems to be essential for asexual growth. 
Table 3 | Summary of rhoptry and microneme phospho-peptides and phospho-proteins observed in the schizont stage of P. 
falciparum-infected red blood cells.
PlasmoDB 
protein 
accession 
number
Protein name 
 
 
Peptide sequence 
 
 
Number of 
times the 
peptide is 
observed
Biological replicates 
in which the peptide 
is observed 
Highest 
mascot ion 
score 
Position in 
the protein 
 
PF14_0102 Rhoptry-associated 
protein 1
ntLTPLEELYPTnVnLFnYK 3 s2, s3 85.9 t201
PF14_0102 Rhoptry-associated 
protein 1
RsAsVAGIVGADEEAPPAPK 3 s3, s5 105.0 s183
PF14_0102 Rhoptry-associated 
protein 1
sAsVAGIVGADEEAPPAPK 3 s1, s5 84.2 s181
PF14_0102 Rhoptry-associated 
protein 1
sAsVAGIVGADEEAPPAPK 24 s1, s2, s3, s4, s5, s6 98.7 s183
PFL2505c Rhoptry neck 
protein 3
DKsDDDQsTTADVLstDTDDsETDAEK 3 s3, s6 74.6 t1704
PFI0265c RhopH3 QHsAHFLDAIAEK 21 s1, s4, s5, s6 61.9 s754
PF14_0637 Rhoptry protein EYIHsDnVsYDDDIK 5 s3, s4, s5 52.4 s1150
PF14_0495 Rhoptry neck 
protein 2
DGYLsEsER 4 s3, s4, s5 43.1 s827
PFC0120w CLAG 3.1 KPsVHsFnR 4 s3, s5 41.1 s1192
PFC0120w CLAG 3.1 KQTsTYIDTEK 21 s1, s2, s3, s5 68.2 s1382
PFC0120w CLAG 3.1 mnEADsADsDDEKDsDTPDDELmIsR 2 s3, s6 39.4 s1398
PFC0120w CLAG 3.1 QTsTYIDTEK 2 s2, s5 62.6 s1382
PF11_0344 Apical membrane 
antigen 1
s*ns*RnDEmLDPEAsFWGEEK 9 s3, s5, s6 58.9 s588/s590
PF11_0344 Apical membrane 
antigen 1
s*ns*RnDEmLDPEAsFWGEEK 8 s3, s5, s6 76.4 s588/s590
PF11_0344 Apical membrane 
antigen 1
s*ns*RnDEmLDPEAsFWGEEK 15 s3, s5, s6 100 s588/s590
The phospho-acceptor sites are indicated by the lower case amino acid in the sequence. The number of times the peptide was observed in six biological replicates together with the biological replicate 
in which the peptide was observed is shown.
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Table 4 | Summary of parasite protein kinases and kinase regulatory proteins that were observed as phospho-proteins in the 
schizont stage of P. falciparum-infected red blood cells.
PlasmoDB 
protein 
accession 
number
Protein name 
 
 
Peptide sequence 
 
 
Number of 
times the 
peptide is 
observed
Biological 
replicates in which 
the peptide is 
observed
Highest 
mascot 
ion 
score
Position 
in the 
protein 
PF13_0258 Serine/threonine protein kinase 
(PfTKL3)
GAtFPETHDDR 3  S3, S5 46.3 t1268
PF13_0258 Serine/threonine protein kinase 
(PfTKL3)
NNNDINNSsDTLQR 2  S3, S5 80.9 s1539
PFF1370w Protein kinase (PfPK4) KNNAPNLVFYsDNDGLTSK 3  S3, S6 60.8 s2318
PFF1370w Protein kinase (PfPK4) NHNPFLsDK 3  S4, S5 45.3 s2340
*PFD0865c* Cdc2-related protein kinase 1 (Pfcrk-1) FGHVTnHnFtK 4  s3, s4 37.3 t514
*mAL13P1.185* Protein kinase 6 (PfPK6) sDHmtPTVVTLWYR 2  s2, s5 34.8 t173
PFD0740w Cyclin-dependent kinase (Pfcrk-3) FHSDINASNmtNR 6  S3, S4, S5 64.1 t778
PFD0740w Cyclin-dependent kinase (Pfcrk-3) FHSDINASNMtNR 14  S1, S3, S4, S5, S6 75.0 t778
PFC0755c Protein kinase, putative (Pfcrk-4) GmINDEDsAAEYDFSFQR 3  S3, S6 64.8 s977
PFC0755c Protein kinase, putative (Pfcrk-4) GMINDEDsAAEYDFSFQR 4  S3, S5 86.3 s977
PFC0755c Protein kinase, putative (Pfcrk-4) NQYsPSLETVQR 8  S1, S2, S4, S5 54.0 s997
PF14_0431 Serine/threonine kinase (PfCLK1) KIsFNNSTNNK 2  S1, S5 45.8 s375
PF14_0408 Serine/threonine protein kinase 
(PfCLK2)
NSsPNFGIFNESIK 4  S2, S3, S4 64.5 s367
*PF11_0156* ser/Thr protein kinase (PfCLK3) VcDLGsAsDIsEnEITsyLVsR 14  s2, s3, s5 150.0 y526
PFC0105w Serine/threonine protein kinase 
(PfCLK4)
LRPSNsDPSLLTSYSNIH 
ALQETLTR
2  S3, S5 53.2 s505
PFC0105w Serine/threonine protein kinase 
(PfCLK4)
NIDsNNTMNDLGNNQNSHK 2  S3, S5 47.9 s646
PFC0105w Serine/threonine protein kinase 
(PfCLK4)
NNsNSNNFIYDGHNSSK 6  S1, S3, S5, S6 82.7 s880
PFC0105w Serine/threonine protein kinase 
(PfCLK4)
YPNsNDVYK 4  S3, S5, S6 48.7 s601
PFC0525c Glycogen synthase kinase 3 SVSyIcSR 13  S1, S2, S3, S5 50.3 y229
PFB0815w Calcium-dependent protein kinase 1 
(PfCDPK1)
KLGsGAYGEVLLcR 2  S5, S6 113.0 s64
PFB0815w Calcium-dependent protein kinase 1 
(PfCDPK1)
LGsGAYGEVLLcR 4  S2, S3, S6 59.2 s64
PF11_0242 Calcium-dependent protein kinase 
(CDPK7)
GsFsKsQDGIEADVIK 2  s5, s6 39.5 s1447
PF11_0242 Calcium-dependent protein kinase 
(CDPK7)
sQDGIEADVIK 3  s3, s5 44.9 s1447
PFI1280c Protein kinase YnssInLEDQK 5  s1, s3, s5, s6 61.5 s1176
MAL13P1.278 Serine/threonine protein kinase 
(PfARK3) 
TRItPDFISVDK 2  S5, S6 55.2 t2479
PF11_0488 Ser/Thr protein kinase IDQSDENNLDtTEYGK 6  S3, S4, S5, S6 84.2 t669
PF11_0488 Ser/Thr protein kinase LLENFsKEPVNFYTILNK 6  S3, S5 86.3 s680
PFL2280w ser/Thr protein kinase IQsKDTLIIDHVDR 4  s1, s3, s5 54.3 s564
PF11_0220 Protein kinase (PfTKL2) YntIsnLcnIK 2  s2, s3 53.2 t756
PF10_0380 serine/Threonine protein kinase,  
FIKK family
FDGDQEnITssFER 2  s4, s6 53.5 s355
mAL8P1.203 serine/Threonine protein kinase,  
FIKK family
FTcIPTLGFsK 4  s2, s3, s5 40.0 s1099
mAL8P1.203 serine/Threonine protein kinase,  
FIKK
nmLsnQDIYnETEnInDs 
TTEcTIVK
2  s5, s6 73.1 s423
mAL8P1.203 serine/Threonine protein kinase,  
FIKK family
YEnPsnTYnDLLnnR 7  s1, s2, s3, s4, s5, 
s6
79.0 s831
mAL8P1.203 serine/Threonine protein kinase,  
FIKK family
YVsnEKLDLDEHTHIYK 3  s3, s6 63.0 s877
PF10_0380 serine/Threonine protein kinase,  
FIKK family
FDGDQEnITssFER 2  s4, s6 53.5 s355
PFI0105c serine/Threonine protein kinase,  
FIKK family
ATAsQDEIFFK 2  s4, s5 45.8 s575
PF14_0143 Atypical protein kinase, ABC-1 family ncLsIsHEYIscDQsR 2  s5, s6 71.9 s498
Protein kinase regulatory subunits
 PFL1110c cAmP-dependent protein kinase 
regulatory subunit
RLsVsAEAYGDWnK 12  s1, s2, s3, s5, s6 73.9 s149
 PFF0270c Cyclin dependent kinase binding 
protein
KGsLnTTsHIK 4  s1, s5, s6 47.3 s156
The phospho-acceptor sites are indicated by the lower case amino acid in the sequence. The number of times the peptide was observed in six biological replicates together with the biological replicate 
in which the peptide was observed is shown. Protein kinase genes highlighted in bold, and those that are flanked by asterisks, are those considered as likely to be essential for parasite viability as 
described in Table 1.
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If its function is indeed to prevent general translation through phos-
phorylation of PfeIF2α (as suggested by its ability to phosphorylate 
an eIF2α peptide in vitro35), it follows that translation inhibition 
through phosphorylation of the translation factor is an essential 
feature at some stage of the erythrocytic asexual cycle. A testable 
hypothesis is that this happens at late stages of merozoite ontogeny 
and in mature merozoites, the only stages of the cycle where transla-
tion is essentially inactive. Noteworthy is the fact that none of the 
available parasite clones with a disrupted kinase gene that have been 
examined thus far display an obvious phenotype in the rate of game-
tocytogenesis; until we have cloned and phenotyped all populations 
with a disrupted gene, we cannot of course exclude the possibility 
that one of these enzymes is required for gametocytogenesis. If a 
specific kinase regulates commitment to gametocytogenesis but is 
also required for (an)other function(s) essential for asexual growth, 
uncovering the former will require conditional expression or activ-
ity of the 36 kinases that are classed in this study as ‘likely essen-
tial’. Some of the ePKs that are not essential for asexual growth have 
already been demonstrated to be required for successful infection of 
the mosquito vector32,36; in light of this we are currently aiming to 
phenotype KO clones of all non-essential ePKs in the mosquito.
Our data indicate that a total of 36 ePKs (Table 1) are likely to 
have an essential role in the P. falciparum erythrocytic asexual cycle 
and that 26 ePKs are likely to be dispensable (Table 2). In com-
parison, a recent study of 66 ePKs of the rodent malaria parasite P. 
berghei identified 43 protein kinases that are refractory to deletion in 
the blood stage and 23 whose genes could be deleted37 (Supplemen-
tary Table S1). Although there is overall a good level of agreement 
between the ePKs identified as essential in the mouse parasite and 
those we identify here to be have a crucial role in P. falciparum (Sup-
plementary Table S1), there are nevertheless differences, which may 
underlie divergence between human and mouse malarial species 
resulting from a split estimated to have occurred 70 million years 
ago. We emphasise here that formal demonstration that a given 
ePK gene is not essential for asexual schizogony requires analysis of 
clones from the populations displaying evidence for gene disruption 
or deletion; this has been achieved for the entire P. berghei kinome37 
but thus far only partially in P. falciparum.
Overall, the phospho-proteomic analysis reported here dem-
onstrates that protein phosphorylation is widely employed in the 
regulation of cellular processes within the asexual blood stage of 
P. falciparum. This not only includes general house-keeping func-
tions such as metabolism, DNA replication and transcription but 
also parasite-specific processes such as red blood cell invasion and 
cyto-adherence. Furthermore, the identification of tyrosine phos-
phorylation within the activation loop of essential protein kinases 
presents evidence for tyrosine phosphorylation being important in 
the viability of the blood stage parasite.
The importance of protein phosphorylation in the viability of the 
human malaria parasite is further supported by the fact that ~half 
of the parasite ePKs are likely to be essential for the blood stage 
parasites. Thus, the extensive phospho-proteome together with the 
lack of redundancy among many of the ePKs supports the notion 
that targeting parasite protein phosphorylation at the blood stage 
may represent an effective strategy for the treatment of P. falciparum 
infection.
One of the major drawbacks of targeting protein kinases in 
human disease is the fact that selective inhibitors are considered 
difficult to generate due to the fact that many inhibitors target the 
conserved ATP-binding site38. It is, however, possible to build selec-
tivity into ATP-competitive inhibitors by extending the interaction 
of the inhibitor molecules to non-conserved allosteric sites located 
within a hydrophobic pocket adjacent to the ATP-binding site38,39. 
This strategy has been successfully employed for a number of pro-
tein kinase inhibitors designed to target human kinases in the treat-
ment of cancer40 including the clinically approved Bcr–Abl inhibitor 
Imatinib (Gleevec)41. That a similar approach to drug design may be 
effective in the search for molecules with selectivity against malaria 
is supported by the significant phylogenetic diversity between the 
human and plasmodial kinomes4. Such a strategy relies on the phar-
macological compounds obtaining access to the allosteric sites. This 
is determined primarily by a gatekeeper residue situated on the β5 
strand of region V, which is distal to the active site and adjacent 
to the hinge region. If the gatekeeper residue is bulky (for exam-
ple, phenylalanine) then access to the allosteric sites are blocked, 
whereas a small (for example, threonine) or even a medium-sized 
(methionine) gatekeeper residue would allow access38. Importantly, 
of the 36 protein kinases determined likely to be essential for the 
blood stage 4 have a small gatekeeper residue (threonine) and 11 
have a medium-sized gatekeeper (methionine). Exploiting the 
accessibility of the allosteric sites within these enzymes provides 
a strategy for the development of selective parasite protein kinase 
inhibitors with parasiticidal activity.
It is possible that one source of these novel kinase inhibitors may 
be found within recent screening programmes that have identified 
thousands of chemical entities with anti-malarial activity, many of 
which have chemo-forms consistent with protein kinase inhibitors42. 
Mining the results of these screens to identify drug-like compounds 
that target essential parasite protein kinases and phosphorylation 
pathways might provide a potential route to the next generation of 
anti-malarials.
Methods
Accessing the phospho-proteomic data. All of the manually validated phos-
pho-peptides observed in this study are listed in Supplementary Data 1 and 2. 
In addition we have made available the SCAFFOLD file containing all the mass 
spectrometry data associated with this manuscript. This may be downloaded from 
https://proteomecommons.org, using the following Tranche hash:
JtHgFyh9HqIYMNWlXk2BTxavNlZutqY1fwalNMWAxEu7GmsuVFw0xQz 
UAuGf/3ZKgnXmZb33wtuawOhR33cSO0QY2TsAAAAAAAAEvA =  = 
To view the SCAFFOLD file it will be necessary to download the SCAFFOLD 
viewer, which is free from the following site http://www.proteomesoftware.com/
Construction of knockout plasmids. For each ePK, a fragment from the open 
reading frame (typically ~500 bp in length) was amplified by PCR and inserted 
between the BamHI and NotI sites of the pCAM-BSD plasmid43 which contains the 
Aspergillus terrus blasticidine-S-deaminase gene, whose gene product confers resist-
ance to the drug Blasticidin. Cloning primers are listed in Supplementary Data 3.
Construction of the complementation plasmids. Plasmids for in vivo episomal 
expression of selected ePKs (see Table 1) were constructed as follows: the full-
length coding sequence was first inserted between the BglII and NotI sites of the 
plasmid pHGB44 and then transferred into the plasmid pCHD-1/2 by a Gateway 
LR clonase reaction according to the manufacturer’s instructions (Invitrogen). The 
plasmid pCHD-1/2 includes a cassette-encoding hDHFR, conferring resistance to 
the antifolate drug WR99210. Parasites that were transfected with both a knockout 
plasmid and a complementation plasmid were cultured under double drug selec-
tion (Supplementary Methods).
Phospho-amino acid analysis. Magnetic cell sorting-purified iRBC (~50 µl pellet 
volume) were resuspended in 500 µl Krebs buffer (phosphate free) and incubated 
with 20–25 µl fresh 32P-orthophosphate for 30 min at 37 °C. Following incubation 
the pellet was washed twice with 1 ml PBS containing protease and phosphotase 
inhibitors (Roche) and lysed with lysis buffer: 50 mM Tris, 0.5 mM EDTA, 5% 
β-glycerophosphate, pH7.6, supplemented with protease/phosphatase inhibitors 
(Roche) and 1% NP-40. The lysate was prepared and purified by means of 2-D 
Clean-Up Kit (Amersham Biosciences) following the manufacturer’s instruc-
tions. Final pellets were briefly air dried and resuspended in 20 µl 6 M HCl and 
immediately placed in preheated to 110 °C oven for hydrolysis. After 1 h hydrolysis 
samples were cooled down to room temperature, resuspended in 400 µl H2O and 
spun 5 min at 21,000 g. The supernatant fractions were dried at 30 °C on a speedvac 
centrifuge. The pellets were dissolved in 40 µl H2O and dried on speedvac again. 
The last procedure was repeated two more times. The final pellets were dissolved in 
30 µl of electrophoresis buffer, pH 1.9, composed of 50 ml 88% formic acid, 156 ml 
glacial acetic acid and 1,794 ml H2O. A volume of 10 µl of each sample was mixed 
with 1 µl of unlabelled phosphor-amino acid standards, comprising 1.5 mg of each 
phospho-serine, phospho-threonine and phospho-tyrosine in total volume of 1 ml. 
The mixture of standards and labelled amino acids was spotted (in 0.5 ml aliquots) 
on the origin of a 20×20 cm glass backed cellulose thin-layer chromatography plate 
(Merck) and two samples originated from RBC cytosol and P. falciparum lysate 
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Figure 3 | Determination of tyrosine phosphorylation in P. falciparum including tyrosine phosphorylation of PfGSK3. (a) 106 Human RBCs or the same 
number for infected schizont stage RBCs were labelled with [32P]-orthophosphate. The cells were then lysed in 1%nP-40 lysis buffer and the sample was 
resolved by sDs-polyacrylamide gel electrophoresis (PAGE). Before an autoradiograph was obtained (right panel) the gel was stained with coomassie blue 
(left panel). (b) The lysate from metabolically labelled schizont stage parasites was also processed for analysis of the phospho-amino acids. shown is an 
autoradiograph from such an experiment where the positions of phosphorylated amino-acid standards are indicated. The spots corresponding to each of the 
standards were scrapped and the radioactive content determined by liquid scintillation counting. The relative amounts of radioactivity associated with each 
phospho-amino acid were then calculated. shown is a representative result from three independent experiments. (c) schizont stage-infected RBCs were either 
lysed in 1% nP-40 to give total iRBC sample or fractionated into a RBC fraction (iRBC fraction) or parasite fraction following saponin lysis. Controls were 
bacterial lysates and non-infected RBC lysates. The samples (20 µg) were resolved by sDs-PAGE and the gels probed in a western blot using an anti-phospho 
tyrosine antibody. To determine the loading of proteins, gels were stained with Ponceau stain. (d) An example of a typical LC-ms/ms trace identifying 
phosphorylation at Y229 within the activation loop of PfGsK3. (e) sequence of PfGsK3 showing the activation loop (underlined) and the position of phospho-
Y229 highlighted in red. (f) Bacteria transformed with an expression plasmid containing either PfGsK3 or as a control PfCK2α (CnT) were either induced or 
non-induced with IPTG. These bacteria were lysed and the extract (20 µg) was used in western blots probed with antibodies against the human GsK3α/β (left 
panel) or an antibody against human tyrosine-phosphorylated GsK3α/β-pY279/216 (right panel). (g) Confirmation of the phosphorylation of PfGsK3 at Y229 in 
a western blot using a commercial antibody against the tyrosine phosphorylation site on human GsK3α/β-pY279/216. Lysates (20 µg) were obtained from 106 
infected RBCs or the same number of non-infected RBCs (as a control). The experiments shown are representative of at least three independent experiments.
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Figure 4 | Tyrosine phosphorylation of PfCLK3. (a) An example of a typical LC-ms/ms trace identifying phosphorylation at Y526 within the activation 
loop of PfCLK3. (b) sequence of PfCLK3 showing the activation loop (underlined) and the position of phospho-Y526 highlighted in red. (c) Bacteria 
transformed with an expression plasmid containing either PfCLK3 or as a control PfPKA (CnT) were either induced or non-induced with IPTG. These 
bacteria were lysed and the extract (20 µg) was used in western blots probed with structural antibodies against the PfCLK3 (middle panel) or antibodies 
against tyrosine 526 on PfCLK3 (right hand panel). The coomassie stain of the samples is shown as a loading control on the left. (d) Bacterially expressed 
PfCLK3 or a mutant of PfCLK3 where Y526 was mutated to a phenylalanine (Y-F) was purified and resolved by sDs-polyacrylamide gel electrophoresis.  
The gel was probed in a western blot with antibodies against tyrosine 526 on PfCLK3 (anti-pY526) or as a loading control structural antibodies against  
the PfCLK3 (anti-PfCLK3). (e) saponin-treated schizont parasite extract was immunoprecipitated with structural antibodies against the PfCLK3  
(Anti-PfCLK3) or control immunoglobulin G (antibodies to an unrelated protein the m1-muscarinic receptor). The immunoprecipitate was then probed in 
a western blot with antibodies against tyrosine 526 on PfCLK3 (anti-pY526). (f) The activity of purified bacterially expressed PfCLK3 was determined in  
in vitro kinase assays containing either no substrates or Histone 2A, myelin basic protein (mBP) or α-casein. shown is a representative autoradiograph 
of the phosphorylated substrates with a coomassie stain of the same gel as a loading control. (g) Purified bacterially expressed PfCLK3 or a mutant of 
PfCLK3 where Y526 was mutated to a phenylalanine (Y-F) (0.5 µg) was used in an in vitro kinase assays with myelin basic protein (mBP) as a substrate. 
shown is a representative autoradiograph and below the cumulative mean data of three independent experiments ± s.d. (n = 3).
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were run in parallel in the first-dimension electrophoresis (pH 1.9) at 2000 V for 
20–25 min in HTLE 7002 apparatus (Tony Hunter). The plate was air dried for 1 h 
before the second run was applied. The second-dimension electrophoresis buffer 
was composed of 100 ml glacial acetic acid, 10 ml pyridine, 10 ml 100 mM EDTA 
and 1,880 ml H2O, pH 3.5. For the second run the plate was rotated 90° counter-
clockwise and the second-dimension electrophoresis was run at 1,800 V for 20 min. 
At the end of the run the plate was air dried for 1 h. To visualize the phospho-
amino acid standards the plate was sprayed with 0.25% ninhydrin in acetone, then 
placed to the preheated oven (80–100 °C) for 5–10 min. Autoradiographs were 
performed in standard way by exposing at  − 80 °C overnight. Radioactive spots 
corresponding to phospho-amino acid standards were scrapped off from the plate 
and counted in scintillation counter.
Ion-exchange fractionation of P. falciparum lysates. Magnetic cell sorting-puri-
fied P. falciparum parasites pellets (32P-labelled or ‘cold’) were resuspended in lysis 
buffer: 50 mM Tris, 0.5 mM EDTA, 5% β-glycerophosphate, pH7.6, supplemented 
with protease/phosphatase inhibitors (Roche) and 1% NP-40. Following incubation 
on ice for 10 min, the samples were centrifuged 3 min at 21,000 g (bench centrifuge) 
and the supernatants (in average 250–300 µl per medium pellet) were collected for 
further fractionation. Fractionation was carried out on an AKTA chromatographer 
(Amersham Pharmacia Biotec) using Resource Q (Amersham Pharmacia Biotec) 
anion-exchange columns (matrix volume 1 ml) in running buffer composed of 
10 mM Tris, 5 mM EDTA and 20 mM β-glycerophosphate, pH7.4. The column 
batch was eluted with 1 M NaCl in a volume of 1 ml if the sample was going to be 
used in a tryptic digest. Alternatively, the proteins were eluted from the RQ column 
using a linear gradient of 0–1 M NaCl and 1 ml fractions were collected for use in 
experiments such as western blotting.
To further prepare the samples for tryptic digestion, the pH of eluates was 
adjusted to 8–8.5 and treated, first, with 10 mM dithiothreitol in the presence 0.1% 
SDS for 30 min at room temperature to reduce disulphide bridges and, second, 
with 100 mM iodoacetamide for 1 h at room temperature (in dark) for alkylation 
of the reduced bonds. Trichloroacetic acid precipitation of the treated samples was 
performed by addition of 1 volume trichloroacetic acid stock (100% w/v) to 4 vol-
umes of protein solutions. Samples were incubated on ice (10 min) and centrifuged 
at 21,000 g for 5 min. The pellets were washed once with ice-cold acetone (200 µl). 
After drying at room temperature the pellets were resuspended in 100 µl of 1% SDS 
in 50 mM triethylammonium bicarbonate (TEAB) buffer, pH 8.5 and finally diluted 
with 50 mM TEAB buffer, pH 8.5 to final volume 1 ml. If necessary, the samples 
were sonicated 3×5 s before making the final volume 1 ml. pH in the sample was 
adjusted to pH8–8.5. Tryptic digestion was carried out using agarose-immobilized 
trypsin (Thermo Scientific). Agarose beads were equilibrated before being used in 
an overnight digestion. The digested peptides were separated from the beads by 
centrifuging (1 min, 21 000 g) and the supernatant was collected. The beads were 
washed with TEAB buffer 2×200 µl, and the supernatant and washes were com-
bined. Digested samples were stored at  − 30 °C until use.
Hydrophilic interaction chromatography. Fractionation of digested peptides 
was performed on HPLC chromatographer (Hewlett Packard, 1100 Series) using 
TSKgel Amide-80 column, 4.6×250 mm, 5 mm particle size (Tosoh Bioscience). 
The column was equilibrated with a mixture of 80% Buffer B (98% acetonitrile, 
0.1% TFA) and 20% Buffer A (98% H2O, 0.1% TFA) at flow rate 500 µl per min. 
Digested peptide solution was concentrated to about 100 µl on speedvac centrifuge 
and diluted with four parts of Buffer B. The precipitate which appeared in the solu-
tion after addition of acetonitrile was removed by centrifugation (5 min, 21,000 g). 
Supernatant fraction was checked for pH and if necessary adjusted to pH 2.5–3.0 
before applying to the column. The pellet was redissolved in a solution com-
posed of 0.25 mM acetic acid, 30% (v/v) acetonitrile and used further for IMAC 
(see below). The supernatant fraction was loaded to the column in 80% Buffer B 
and eluted with decreasing gradient of acetonitrile as follows; (i) 0–5 min 80 % 
acetonitrile, (ii) 5–40 min 60% acetonitrile, (iii) 40–45 min 0% acetonitrile and (iv) 
45–60 min 0% acetonitrile. Fractions (0.5 ml) were collected and directly used for 
immobilised metal affinity chromatography (IMAC) (see below).
Enrichment of phosphopeptides. PHOS-Select iron affinity gel (Sigma) was 
equilibrated with 5×1 ml IMAC load/wash buffer: 0.25 mM acetic acid, 30% (v/v) 
acetonitrile. A volume of 50 µl of 50% slurry of the resin was added directly to each 
1 ml hydrophilic interaction liquid chromatography fraction. Samples were left on 
a rotating platform for 2 h at room temperature. Following incubation the fractions 
were transferred to the spin columns (MoBiTec GmbH) and centrifuged 30 s at 
8,200 g. The flow-through (unbound peptides) were collected and concentrated 
on a speedvac centrifuge to small volume for further liquid chromatography-mass 
spectrometry (LC-MS)/MS analysis. The columns were washed twice with 200 µl 
of IMAC load/wash buffer and once with 200 µl of HPLC-grade H2O. Phospho-
peptides bound to the resin were eluted with 2×100 µl solution composed of 0.4 M 
ammonium hydroxide, 30% (v/v) acetonitrile. The eluate was concentrated on a 
speedvac to a volume of 20 µl and analysed by LC-MS-MS analysis.
The flow through from the IMAC resin was passed through a MonoTip TiO2 
Pipette Tip columns (GL Sciences Inc) following the manufacturer’s instructions. 
Peptides were eluted with 3.5% ammonia hydroxide and analysed by LC-MS/MS.
The pellets which originated from insoluble in 80% acetonitrile peptide fraction 
(see above) were dissolved in IMAC load/wash buffer and the sample processed 
over the PHOS-Select iron affinity gel following the same protocol as described 
above. Parasite culture methods, antibody production, proteomic data analysis 
and mass spectrometry and protein analysis are described in the Supplementary 
Methods. 
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